Reactions 1704, p212 - 2 Jun 2018 Hepatotoxicity and widespread arthralgias: case report A 61-year-old woman developed hepatotoxicity during treatment with isoniazid and widespread arthralgias during treatment with pyrazinamide for cutaneous infection of Mycobacterium tuberculosis [routes not stated]. The woman presented with a solitary large black nodular lesion overlying her right proximal interphalangeal joint on her index finger since last one year. Considering a possibility of mycobacterial infection, she was empirically treated with anti- mycobacterial therapy, which consisted of isoniazid 300 mg/day, rifampicin, ethambutol, pyrazinamide 1.5 g/day and pyridoxine. It was later confirmed that she had Mycobacterium tuberculosis infection. A clinical response was obtained, however, she subsequently developed isoniazid- induced hepatotoxicity and widespread arthralgias [durations of treatments to reactions onsets not stated]. It was suspected that the arthralgia was secondary to pyrazinamide. The woman’s isoniazid and pyrazinamide therapies were consequently stopped, and the anti-tuberculous therapy was switched to moxifloxacin and clarithromycin [outcomes not stated]. Author comment: "Despite a clinical response, isoniazid was ceased secondary to isoniazid-induced hepatotoxicity, pyrazinamide was ceased due to widespread arthralgias." Laidler N. Cutaneous infection with paucibacillary mycobacterium tuberculosis treated successfully with a modified antituberculous drug regimen. Australasian Journal of Dermatology 59 (Suppl. 1): 80 (plus poster), 27 Apr 2018. Available from: URL: https://doi.org/10.1111/ajd.17_12815 [abstract] - Australia 803323609 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud